<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02099799</url>
  </required_header>
  <id_info>
    <org_study_id>O1150-R</org_study_id>
    <nct_id>NCT02099799</nct_id>
  </id_info>
  <brief_title>The Effect of Physical Activity Promotion on Short and Long-term Outcomes in COPD</brief_title>
  <acronym>WEB</acronym>
  <official_title>The Effect of Physical Activity Promotion on Short and Long-term Outcomes in COPD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      COPD currently afflicts 24 million US residents; the prevalence of COPD is high among&#xD;
      Veterans. Persons with COPD have significant functional disability as a result of the&#xD;
      disease. This project will determine whether a novel Internet-mediated walking program&#xD;
      coupled with a pedometer can improve exercise capacity, improve health-related quality of&#xD;
      life, and decrease the risk of acute exacerbations in persons with COPD. If successful, based&#xD;
      on estimates that 33 to 64% of COPD patients are Internet users, the proposed exercise&#xD;
      intervention could help over 8 million persons. The Veterans Health Administration (VHA) has&#xD;
      a strong commitment to providing care to persons with COPD and supporting research directed&#xD;
      at COPD-related disability. The 2012-2016 Strategic Plan of the VHA Office of Research and&#xD;
      Development includes research in COPD rehabilitation. The proposed research addresses&#xD;
      Rehabilitation R&amp;D Service's current priority area of improving disabled Veterans'&#xD;
      health-related quality of life by reducing disease burden and maximizing functional recovery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic obstructive pulmonary disease (COPD) is a major cause of global morbidity and is&#xD;
      projected to become the third leading cause of death in the world by 2020. In Veterans, the&#xD;
      prevalence is high; in VISN1 in FY 2012, 9% of outpatient Veterans had the ICD-9 diagnosis of&#xD;
      COPD. In COPD, shortness of breath leads to physical inactivity and significant disability. A&#xD;
      growing body of knowledge has identified physical activity and exercise as a modifiable&#xD;
      factor that may impact COPD-related morbidity and mortality. Epidemiological and&#xD;
      cross-sectional studies have shown that persons with COPD who are more physically active have&#xD;
      better functional status and are less likely to be hospitalized and to die. A higher daily&#xD;
      step count, when directly measured, is associated with lower risk of acute exacerbations&#xD;
      (AEs) and mortality in COPD, independent of lung function. Despite the potential benefits,&#xD;
      there have been few interventions to increase walking in persons with COPD. Although&#xD;
      supervised pulmonary rehabilitation programs improve exercise capacity, they are not&#xD;
      accessible to all who could benefit from them and have low adherence rates.&#xD;
&#xD;
      Novel interventions that incorporate strategies for behavioral change and that are&#xD;
      accessible, individualized, and sustained are needed to promote physical activity in persons&#xD;
      limited by COPD. Funded by a RR&amp;D CDA-2 Dr. Moy and her team have developed and piloted a&#xD;
      novel exercise intervention that combines a website with a pedometer to promote walking in&#xD;
      persons with COPD. The program, Every Step Counts (ESC) for Lung Health, accurately monitors&#xD;
      walking, provides iterative feedback and individualized goal-setting, and delivers education&#xD;
      and motivation.&#xD;
&#xD;
      This study proposes a 2-arm randomized, controlled trial to study the efficacy of ESC to&#xD;
      improve exercise capacity in persons with COPD, compared to usual care (verbal and written&#xD;
      instructions to exercise).&#xD;
&#xD;
      Primary Aim: Determine the efficacy of the ESC intervention to increase 6-minute walk test&#xD;
      (6MWT) distance.&#xD;
&#xD;
      Secondary Aims: Estimate the effect of the ESC intervention on (a) health-related quality of&#xD;
      life (HRQL), as measured by the St. George's Respiratory Questionnaire (SGRQ), (b) dyspnea,&#xD;
      (c) inflammatory biomarkers C-reactive protein (CRP) and interleukin-6 (IL-6), (d) risk for&#xD;
      AEs and COPD-related hospitalizations, and (e) engagement in physical activity as measured by&#xD;
      daily step count.&#xD;
&#xD;
      185 subjects will be enrolled for a total of 12 months, with the interventional phase being 6&#xD;
      months followed by an observational phase of 6 months. Subjects will be randomized (1:1&#xD;
      ratio) to one of 2 arms: (1) verbal and written instructions to exercise at home (usual care)&#xD;
      or (2) usual care plus pedometer and Internet-mediated walking program. Subjects will perform&#xD;
      6MWTs, complete questionnaires, and have blood drawn at clinic visits at baseline, 3, 6, and&#xD;
      12 months. Telephone contact will occur at 9 months. AE history and daily step count will be&#xD;
      assessed at each contact. Analysis of variance will compare 6MWT distance in the intervention&#xD;
      and usual care group at 6 months. Multivariate regression models will assess 6MWT distance as&#xD;
      a function of treatment group, adjusting for baseline 6MWT distance, study site, season of&#xD;
      enrollment, and any unbalanced baseline characteristics.&#xD;
&#xD;
      This study hypothesizes that persons randomized to ESC will have greater 6MWT distance at 6&#xD;
      months, compared to persons in the usual care group. It also hypothesize that persons&#xD;
      randomized to ESC will have greater improvements in HRQL, dyspnea, daily step counts, and&#xD;
      greater decreases in levels of inflammatory biomarker and risk for AEs and COPD-related&#xD;
      hospitalizations, compared to control.&#xD;
&#xD;
      The proposed intervention has the potential to (1) bring an exercise program to the vast&#xD;
      majority of persons with COPD who cannot go to a hospital-based pulmonary rehabilitation&#xD;
      program, (2) improve the effectiveness of current rehabilitation programs by sustaining&#xD;
      long-term exercise, and (3) become an effective and integral part of COPD self-management&#xD;
      programs. Ultimately, the intervention could decrease risk of hospitalizations, AEs, and&#xD;
      COPD-related morbidity and mortality.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 17, 2015</start_date>
  <completion_date type="Actual">February 7, 2020</completion_date>
  <primary_completion_date type="Actual">November 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Research assistant who assesses outcomes is blinded to randomization group.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>6-Minute Walk Test Distance</measure>
    <time_frame>6 months</time_frame>
    <description>In-clinic test that measures exercise capacity. Change in 6MWT distance at 6 months compared to baseline.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Health-related Quality of Life</measure>
    <time_frame>6 months</time_frame>
    <description>Questionnaires that assess quality of life. St. George's Respiratory Questionnaire Total Score Scores range 0-100 Higher score reflects worse HRQL. Change at 6 months compared to baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspnea</measure>
    <time_frame>6 months</time_frame>
    <description>Assessed by questionnaire that measure breathlessness and shortness of breath. mMRC dyspnea score Scores range 0-4. Higher values reflect more shortness of breath.&#xD;
Change at 6 months compared to baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Engagement in Physical Activity</measure>
    <time_frame>6 months</time_frame>
    <description>Assessed by daily step counts on pedometer.&#xD;
Change at 6 months compared to baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory Biomarker Number 1</measure>
    <time_frame>6 months</time_frame>
    <description>RAGE-receptor of advanced glycation end-products</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Inflammatory Biomarker Number 2</measure>
    <time_frame>6 months</time_frame>
    <description>Inflammatory protein biomarker NT-proBNP (beta natriuretic peptide)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">153</enrollment>
  <condition>COPD</condition>
  <condition>Emphysema</condition>
  <condition>Chronic Bronchitis</condition>
  <arm_group>
    <arm_group_label>Pedometer and Internet Website</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pedometer and website with feedback, goal setting, educational and motivational content, and community forum.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Verbal instructions and written materials about exercise.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Pedometer and Website</intervention_name>
    <description>Pedometer and website with feedback, goal setting, educational and motivational content, and community forum.</description>
    <arm_group_label>Pedometer and Internet Website</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male and female subjects, greater than or equal to 40 years of age&#xD;
&#xD;
          -  Clinical diagnosis of COPD defined as either a ratio of FEV1 to forced vital capacity&#xD;
             &lt; 0.70 or chest CT evidence of emphysema. CT obtained as part of routine clinical&#xD;
             care, independent of research study.&#xD;
&#xD;
          -  Medical clearance from healthcare provider to participate in an exercise program&#xD;
&#xD;
          -  Have an active email account and can check email at least weekly&#xD;
&#xD;
          -  Have access to a computer with Internet connection or willing to come to VABoston or&#xD;
             Birmingham VA Medical Center to use study computers&#xD;
&#xD;
          -  Pedometer with &gt;90% accuracy compared to manual counts on short clinic walk&#xD;
&#xD;
          -  Competent to provide informed consent&#xD;
&#xD;
          -  Willingness to make return visits and be available by telephone for duration of study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  COPD exacerbation in the previous 1 month&#xD;
&#xD;
          -  Unable to ambulate with or without assistance&#xD;
&#xD;
          -  Clinical signs of unstable cardiovascular disease or congestive heart failure&#xD;
&#xD;
          -  Hypoxemia during 6MWT, i.e. oxygen saturation &lt;85% using supplemental oxygen&#xD;
&#xD;
          -  Unable to complete questionnaires&#xD;
&#xD;
          -  Unable to collect at least 5 of 7 days of baseline step counts&#xD;
&#xD;
          -  Participation in a pulmonary rehabilitation program at time of screening or within the&#xD;
             previous 3 months&#xD;
&#xD;
          -  Participation in another exercise-related research study at time of screening&#xD;
&#xD;
          -  Plans to participate in an exercise-related research study in the next 6 months&#xD;
&#xD;
          -  Plans to enroll in a supervised exercise program, such as pulmonary rehabilitation, in&#xD;
             the next 6 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marilyn L. Moy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Birmingham VA Medical Center, Birmingham, AL</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Moy ML, Matthess K, Stolzmann K, Reilly J, Garshick E. Free-living physical activity in COPD: assessment with accelerometer and activity checklist. J Rehabil Res Dev. 2009;46(2):277-86.</citation>
    <PMID>19533541</PMID>
  </reference>
  <reference>
    <citation>Moy ML, Janney AW, Nguyen HQ, Matthess KR, Cohen M, Garshick E, Richardson CR. Use of pedometer and Internet-mediated walking program in patients with chronic obstructive pulmonary disease. J Rehabil Res Dev. 2010;47(5):485-96.</citation>
    <PMID>20803392</PMID>
  </reference>
  <reference>
    <citation>Moy ML, Teylan M, Danilack VA, Gagnon DR, Garshick E. An index of daily step count and systemic inflammation predicts clinical outcomes in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014 Feb;11(2):149-57. doi: 10.1513/AnnalsATS.201307-243OC.</citation>
    <PMID>24308588</PMID>
  </reference>
  <reference>
    <citation>Danilack VA, Weston NA, Richardson CR, Mori DL, Moy ML. Reasons persons with COPD do not walk and relationship with daily step count. COPD. 2014 Jun;11(3):290-9. doi: 10.3109/15412555.2013.841670. Epub 2013 Oct 23.</citation>
    <PMID>24152213</PMID>
  </reference>
  <reference>
    <citation>Moy ML, Teylan M, Weston NA, Gagnon DR, Danilack VA, Garshick E. Daily step count is associated with plasma C-reactive protein and IL-6 in a US cohort with COPD. Chest. 2014 Mar 1;145(3):542-550. doi: 10.1378/chest.13-1052.</citation>
    <PMID>24091482</PMID>
  </reference>
  <reference>
    <citation>Moy ML, Teylan M, Weston NA, Gagnon DR, Garshick E. Daily step count predicts acute exacerbations in a US cohort with COPD. PLoS One. 2013 Apr 4;8(4):e60400. doi: 10.1371/journal.pone.0060400. Print 2013.</citation>
    <PMID>23593211</PMID>
  </reference>
  <reference>
    <citation>Moy ML, Danilack VA, Weston NA, Garshick E. Daily step counts in a US cohort with COPD. Respir Med. 2012 Jul;106(7):962-9. doi: 10.1016/j.rmed.2012.03.016. Epub 2012 Apr 20.</citation>
    <PMID>22521225</PMID>
  </reference>
  <reference>
    <citation>Moy ML, Garshick E, Matthess KR, Lew R, Reilly JJ. Accuracy of uniaxial accelerometer in chronic obstructive pulmonary disease. J Rehabil Res Dev. 2008;45(4):611-7.</citation>
    <PMID>18712646</PMID>
  </reference>
  <reference>
    <citation>Moy ML, Collins RJ, Martinez CH, Kadri R, Roman P, Holleman RG, Kim HM, Nguyen HQ, Cohen MD, Goodrich DE, Giardino ND, Richardson CR. An Internet-Mediated Pedometer-Based Program Improves Health-Related Quality-of-Life Domains and Daily Step Counts in COPD: A Randomized Controlled Trial. Chest. 2015 Jul;148(1):128-137. doi: 10.1378/chest.14-1466.</citation>
    <PMID>25811395</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 20, 2014</study_first_submitted>
  <study_first_submitted_qc>March 26, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 31, 2014</study_first_posted>
  <results_first_submitted>December 18, 2020</results_first_submitted>
  <results_first_submitted_qc>December 18, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 14, 2021</results_first_posted>
  <last_update_submitted>August 10, 2021</last_update_submitted>
  <last_update_submitted_qc>August 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Physical Activity</keyword>
  <keyword>COPD Self-Management</keyword>
  <keyword>Internet</keyword>
  <keyword>6-Minute Walk Test</keyword>
  <keyword>COPD Exacerbation</keyword>
  <keyword>Health-related Quality of Life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchitis</mesh_term>
    <mesh_term>Bronchitis, Chronic</mesh_term>
    <mesh_term>Emphysema</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 21, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/99/NCT02099799/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were enrolled from Nov 2015-Nov 2019 at two US sites. VABoston (BOS) and VABirmingham (BIR).&#xD;
204 consented (143 BOS and 61 BIR); 51 not randomized (38 ineligible and 13 withdrew); 153 randomized (108 BOS and 45 BIR); 75 allocated to Pedometer and Internet Website Arm (54 BOS and 21 BIR); 15 Lost to follow-up at 6 months (8 BOS and 7 BIR); 74 included in the analyses.</recruitment_details>
      <pre_assignment_details>51 not randomized (38 ineligible and 13 withdrew)</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Pedometer and Internet Website</title>
          <description>Pedometer and Website: Pedometer and website with feedback, goal setting, educational and motivational content, and community forum.</description>
        </group>
        <group group_id="P2">
          <title>Usual Care</title>
          <description>Verbal instructions and written materials about exercise.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="75"/>
                <participants group_id="P2" count="78"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="54"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Pedometer and Internet Website</title>
          <description>Pedometer and Website: Pedometer and website with feedback, goal setting, educational and motivational content, and community forum.&#xD;
Participants were recruited from May 2015- February 2019 at two US sites. VABoston (BOS) and VABirmingham (BIR).&#xD;
204 consented (143 BOS and 61 BIR) 51 not randomized (38 ineligible and 13 withdrew) 153 randomized (108 BOS and 45 BIR) 75 allocated to Pedometer and Internet Website Arm (54 BOS and 21 BIR) 15 Lost to follow-up at 6 months (8 BOS and 7 BIR) 74 included in the analyses</description>
        </group>
        <group group_id="B2">
          <title>Usual Care</title>
          <description>Verbal instructions and written materials about exercise. Participants were recruited from May 2015- February 2019 at two US sites. VABoston (BOS) and VABirmingham (BIR).&#xD;
204 consented (143 BOS and 61 BIR) 51 not randomized (38 ineligible and 13 withdrew) 153 randomized (108 BOS and 45 BIR) 78 allocated to Pedometer and Internet Website Arm (54 BOS and 24 BIR) 24 Lost to follow-up at 6 months (13 BOS and 11 BIR) 78 included in the analyses</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="75"/>
            <count group_id="B2" value="78"/>
            <count group_id="B3" value="153"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69.2" spread="7.2"/>
                    <measurement group_id="B2" value="70.4" spread="7.3"/>
                    <measurement group_id="B3" value="69.3" spread="7.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="70"/>
                    <measurement group_id="B2" value="72"/>
                    <measurement group_id="B3" value="142"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="69"/>
                    <measurement group_id="B2" value="69"/>
                    <measurement group_id="B3" value="138"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>6-Minute Walk Test Distance</title>
          <units>meters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="360.8" spread="92.0"/>
                    <measurement group_id="B2" value="357.2" spread="103.5"/>
                    <measurement group_id="B3" value="359" spread="97.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>FEV1 percent predicted</title>
          <units>percent</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.6" spread="23.1"/>
                    <measurement group_id="B2" value="61.5" spread="19.8"/>
                    <measurement group_id="B3" value="61.1" spread="21.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Daily Step Count</title>
          <units>steps per day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3242" spread="2177"/>
                    <measurement group_id="B2" value="3320" spread="2278"/>
                    <measurement group_id="B3" value="3281" spread="2222"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>6-Minute Walk Test Distance</title>
        <description>In-clinic test that measures exercise capacity. Change in 6MWT distance at 6 months compared to baseline.</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pedometer and Internet Website</title>
            <description>Pedometer and Website: Pedometer and website with feedback, goal setting, educational and motivational content, and community forum.&#xD;
Participants were recruited from May 2015- February 2019 at two US sites. VABoston (BOS) and VABirmingham (BIR).&#xD;
204 consented (143 BOS and 61 BIR) 51 not randomized (38 ineligible and 13 withdrew) 153 randomized (108 BOS and 45 BIR) 75 allocated to Pedometer and Internet Website Arm (54 BOS and 21 BIR) 15 Lost to follow-up at 6 months (8 BOS and 7 BIR) 74 included in the analyses</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Verbal instructions and written materials about exercise. Participants were recruited from May 2015- February 2019 at two US sites. VABoston (BOS) and VABirmingham (BIR).&#xD;
204 consented (143 BOS and 61 BIR) 51 not randomized (38 ineligible and 13 withdrew) 153 randomized (108 BOS and 45 BIR) 78 allocated to Pedometer and Internet Website Arm (54 BOS and 24 BIR) 24 Lost to follow-up at 6 months (13 BOS and 11 BIR) 78 included in the analyses</description>
          </group>
        </group_list>
        <measure>
          <title>6-Minute Walk Test Distance</title>
          <description>In-clinic test that measures exercise capacity. Change in 6MWT distance at 6 months compared to baseline.</description>
          <units>meters</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="78"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25" spread="10"/>
                    <measurement group_id="O2" value="37" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.189</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-12</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Health-related Quality of Life</title>
        <description>Questionnaires that assess quality of life. St. George's Respiratory Questionnaire Total Score Scores range 0-100 Higher score reflects worse HRQL. Change at 6 months compared to baseline</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pedometer and Internet Website</title>
            <description>Pedometer and Website: Pedometer and website with feedback, goal setting, educational and motivational content, and community forum.&#xD;
Participants were recruited from May 2015- February 2019 at two US sites. VABoston (BOS) and VABirmingham (BIR).&#xD;
204 consented (143 BOS and 61 BIR) 51 not randomized (38 ineligible and 13 withdrew) 153 randomized (108 BOS and 45 BIR) 75 allocated to Pedometer and Internet Website Arm (54 BOS and 21 BIR) 15 Lost to follow-up at 6 months (8 BOS and 7 BIR) 74 included in the analyses</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Verbal instructions and written materials about exercise. Participants were recruited from May 2015- February 2019 at two US sites. VABoston (BOS) and VABirmingham (BIR).&#xD;
204 consented (143 BOS and 61 BIR) 51 not randomized (38 ineligible and 13 withdrew) 153 randomized (108 BOS and 45 BIR) 78 allocated to Pedometer and Internet Website Arm (54 BOS and 24 BIR) 24 Lost to follow-up at 6 months (13 BOS and 11 BIR) 78 included in the analyses</description>
          </group>
        </group_list>
        <measure>
          <title>Health-related Quality of Life</title>
          <description>Questionnaires that assess quality of life. St. George's Respiratory Questionnaire Total Score Scores range 0-100 Higher score reflects worse HRQL. Change at 6 months compared to baseline</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="78"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-13.0" spread="3.6"/>
                    <measurement group_id="O2" value="-15.1" spread="3.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.572</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>2.1</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Dyspnea</title>
        <description>Assessed by questionnaire that measure breathlessness and shortness of breath. mMRC dyspnea score Scores range 0-4. Higher values reflect more shortness of breath.&#xD;
Change at 6 months compared to baseline</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pedometer and Internet Website</title>
            <description>Pedometer and Website: Pedometer and website with feedback, goal setting, educational and motivational content, and community forum.&#xD;
Participants were recruited from May 2015- February 2019 at two US sites. VABoston (BOS) and VABirmingham (BIR).&#xD;
204 consented (143 BOS and 61 BIR) 51 not randomized (38 ineligible and 13 withdrew) 153 randomized (108 BOS and 45 BIR) 75 allocated to Pedometer and Internet Website Arm (54 BOS and 21 BIR) 15 Lost to follow-up at 6 months (8 BOS and 7 BIR) 74 included in the analyses</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Verbal instructions and written materials about exercise. Participants were recruited from May 2015- February 2019 at two US sites. VABoston (BOS) and VABirmingham (BIR).&#xD;
204 consented (143 BOS and 61 BIR) 51 not randomized (38 ineligible and 13 withdrew) 153 randomized (108 BOS and 45 BIR) 78 allocated to Pedometer and Internet Website Arm (54 BOS and 24 BIR) 24 Lost to follow-up at 6 months (13 BOS and 11 BIR) 78 included in the analyses</description>
          </group>
        </group_list>
        <measure>
          <title>Dyspnea</title>
          <description>Assessed by questionnaire that measure breathlessness and shortness of breath. mMRC dyspnea score Scores range 0-4. Higher values reflect more shortness of breath.&#xD;
Change at 6 months compared to baseline</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="78"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="0.2"/>
                    <measurement group_id="O2" value="0.0" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.799</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.1</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Engagement in Physical Activity</title>
        <description>Assessed by daily step counts on pedometer.&#xD;
Change at 6 months compared to baseline.</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pedometer and Internet Website</title>
            <description>Pedometer and Website: Pedometer and website with feedback, goal setting, educational and motivational content, and community forum.&#xD;
Participants were recruited from May 2015- February 2019 at two US sites. VABoston (BOS) and VABirmingham (BIR).&#xD;
204 consented (143 BOS and 61 BIR) 51 not randomized (38 ineligible and 13 withdrew) 153 randomized (108 BOS and 45 BIR) 75 allocated to Pedometer and Internet Website Arm (54 BOS and 21 BIR) 15 Lost to follow-up at 6 months (8 BOS and 7 BIR) 74 included in the analyses</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Verbal instructions and written materials about exercise. Participants were recruited from May 2015- February 2019 at two US sites. VABoston (BOS) and VABirmingham (BIR).&#xD;
204 consented (143 BOS and 61 BIR) 51 not randomized (38 ineligible and 13 withdrew) 153 randomized (108 BOS and 45 BIR) 78 allocated to Pedometer and Internet Website Arm (54 BOS and 24 BIR) 24 Lost to follow-up at 6 months (13 BOS and 11 BIR) 78 included in the analyses</description>
          </group>
        </group_list>
        <measure>
          <title>Engagement in Physical Activity</title>
          <description>Assessed by daily step counts on pedometer.&#xD;
Change at 6 months compared to baseline.</description>
          <units>steps per day</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="78"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="673" spread="392"/>
                    <measurement group_id="O2" value="-639" spread="415"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>1312</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Inflammatory Biomarker Number 1</title>
        <description>RAGE-receptor of advanced glycation end-products</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pedometer and Internet Website</title>
            <description>Pedometer and website with feedback, goal setting, educational and motivational content, and community forum.&#xD;
Pedometer and Website: Pedometer and website with feedback, goal setting, educational and motivational content, and community forum.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Verbal instructions and written materials about exercise.</description>
          </group>
        </group_list>
        <measure>
          <title>Inflammatory Biomarker Number 1</title>
          <description>RAGE-receptor of advanced glycation end-products</description>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.0" spread="319"/>
                    <measurement group_id="O2" value="22.0" spread="243"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.2265</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Inflammatory Biomarker Number 2</title>
        <description>Inflammatory protein biomarker NT-proBNP (beta natriuretic peptide)</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pedometer and Internet Website</title>
            <description>Pedometer and website with feedback, goal setting, educational and motivational content, and community forum.&#xD;
Pedometer and Website: Pedometer and website with feedback, goal setting, educational and motivational content, and community forum.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Verbal instructions and written materials about exercise.</description>
          </group>
        </group_list>
        <measure>
          <title>Inflammatory Biomarker Number 2</title>
          <description>Inflammatory protein biomarker NT-proBNP (beta natriuretic peptide)</description>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.1" spread="498"/>
                    <measurement group_id="O2" value="69.2" spread="314"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8897</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <desc>Significant, pulmonary, and musculoskeletal adverse events were tracked during the study. Significant adverse events were defined as deaths and/or hospitalizations. Pulmonary adverse events were self-reported at 3 and 6 months and included diagnoses of pneumonia and/or acute exacerbation of COPD. Musculoskeletal events were self-reported as chest, leg, foot and/or back pain or discomfort. Serious adverse events were defined as deaths and/or hospitalizations.</desc>
      <group_list>
        <group group_id="E1">
          <title>Pedometer and Internet Website</title>
          <description>Pedometer and Website: Pedometer and website with feedback, goal setting, educational and motivational content, and community forum.&#xD;
Participants were recruited from May 2015- February 2019 at two US sites. VABoston (BOS) and VABirmingham (BIR).&#xD;
204 consented (143 BOS and 61 BIR) 51 not randomized (38 ineligible and 13 withdrew) 153 randomized (108 BOS and 45 BIR) 75 allocated to Pedometer and Internet Website Arm (54 BOS and 21 BIR) 15 Lost to follow-up at 6 months (8 BOS and 7 BIR) 74 included in the analyses</description>
        </group>
        <group group_id="E2">
          <title>Usual Care</title>
          <description>Verbal instructions and written materials about exercise. Participants were recruited from May 2015- February 2019 at two US sites. VABoston (BOS) and VABirmingham (BIR).&#xD;
204 consented (143 BOS and 61 BIR) 51 not randomized (38 ineligible and 13 withdrew) 153 randomized (108 BOS and 45 BIR) 78 allocated to Pedometer and Internet Website Arm (54 BOS and 24 BIR) 24 Lost to follow-up at 6 months (13 BOS and 11 BIR) 78 included in the analyses</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="78"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <description>One death from leukemia. The cause of the other death is unknown.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="75"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalizations</sub_title>
                <description>Mainly for COPD acute exacerbations</description>
                <counts group_id="E1" events="23" subjects_affected="23" subjects_at_risk="75"/>
                <counts group_id="E2" events="24" subjects_affected="24" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="36" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Musculoskeletal adverse event</sub_title>
                <counts group_id="E1" events="36" subjects_affected="36" subjects_at_risk="75"/>
                <counts group_id="E2" events="25" subjects_affected="25" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Strengths include the randomized study design, dual-site approach, and 6-month time frame. While the study expanded our past work with a more socioeconomically diverse sample, our cohort was self-selected and majority male, limiting generalizability.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Marilyn Moy, MD, MSc</name_or_title>
      <organization>VA Boston Healthcare System</organization>
      <phone>857-203-6622</phone>
      <email>marilyn.moy@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

